P344: ONCOGENESIS OF CRLF2 OVEREXPRESSION AND EFFECT OF A NOVEL JAK2 INHIBITOR IN CRLF2 OVEREXPRESSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

P344: ONCOGENESIS OF CRLF2 OVEREXPRESSION AND EFFECT OF A NOVEL JAK2 INHIBITOR IN CRLF2 OVEREXPRESSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Bibliographic Details
Main Authors:	Yan Gu, Chunhua Song, Sinisa Dovat, Zheng Ge
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968288.34900.1e

Similar Items

CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia
by: Maciel, ALT, et al.
Published: (2019)

Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia
by: Elda Pereira Noronha, et al.
Published: (2023-04-01)

Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients
by: Nitin Jain, et al.
Published: (2017-12-01)

Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach
by: José Vicente Gil, et al.
Published: (2024-02-01)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
by: Buitenkamp, T, et al.
Published: (2012)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
by: Buitenkamp, T, et al.
Published: (2012)

BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i>-rearranged acute lymphoblastic leukemia
by: Shinobu Tsuzuki, et al.
Published: (2022-08-01)

P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
by: J. Senapati, et al.
Published: (2022-06-01)

Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis
by: Tobias Herold, et al.
Published: (2017-01-01)

Bilateral parotid gland swelling preceding the diagnosis of acute lymphoblastic leukemia with P2RY8-CRLF2 gene rearrangement
by: Yu-Tang Juan, et al.
Published: (2023-05-01)

Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report
by: Guo-qian He, et al.
Published: (2024-08-01)

P1421: BIMODAL TARGETING OF CYTOKINE RECEPTOR-LIKE FACTOR 2 (CRLF2) WITH JAK INHIBITION AND CHIMERIC ANTIGEN RECEPTOR T CELL IMMUNOTHERAPY IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA
by: A. Bagashev, et al.
Published: (2022-06-01)

Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia
by: Cristina Bugarin, et al.
Published: (2015-06-01)

Gain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression
by: Elyse C. Page, et al.
Published: (2023-07-01)

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
by: Ensor, H, et al.
Published: (2011)

Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes
by: Danna Lin, et al.
Published: (2023-11-01)

A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis
by: Olivia L. Francis, et al.
Published: (2016-04-01)

Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening
by: Athanasios Oikonomou, et al.
Published: (2024-07-01)

Increased AID results in mutations at the CRLF2 locus implicated in Latin American ALL health disparities
by: Valeria Rangel, et al.
Published: (2024-07-01)

A novel approach for direct detection of the IGH::CRLF2 gene fusion by fluorescent in situ hybridization
by: Rosa María González-Arreola, et al.
Published: (2023-08-01)

Cytokine Receptor-like Factor 1 (CRLF1) and Its Role in Osteochondral Repair
by: Fenglin Zhang, et al.
Published: (2024-04-01)

The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor
by: Debbra Y. Knorr, et al.
Published: (2023-04-01)

Protection of insect neurons by erythropoietin/CRLF3-mediated regulation of pro-apoptotic acetylcholinesterase
by: Debbra Y. Knorr, et al.
Published: (2022-11-01)

Cytokine Receptor-Like Factor 3 (CRLF3) Contributes to Early Zebrafish Hematopoiesis
by: Tarannum Taznin, et al.
Published: (2022-06-01)

CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy
by: Nisha Patel, et al.
Published: (2024-10-01)

Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
by: Siyu Gu, et al.
Published: (2023-02-01)

Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.
by: Brendan D Looyenga, et al.
Published: (2013-01-01)

The role of cytokine receptor-like factor 1 (CRLF1) in facet joint osteoarthritis pathogenesis
by: Pengfei Xue, et al.
Published: (2024-10-01)

The Insect Ortholog of the Human Orphan Cytokine Receptor CRLF3 Is a Neuroprotective Erythropoietin Receptor
by: Nina Hahn, et al.
Published: (2017-07-01)

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
Published: (2014-01-01)

Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
by: Charlotte E. J. Downes, et al.
Published: (2021-08-01)

CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer
by: Cong Xiang, et al.
Published: (2024-09-01)

Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia
by: Miroslav Djokic, et al.
Published: (2009-07-01)

The Orphan Cytokine Receptor CRLF3 Emerged With the Origin of the Nervous System and Is a Neuroprotective Erythropoietin Receptor in Locusts
by: Nina Hahn, et al.
Published: (2019-10-01)

New precision medicine weapons for targeted treatment of high-risk B-cell precursor acute lymphoblastic leukemia
by: Sinisa Dovat, et al.
Published: (2024-07-01)

TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors
by: Peh Bee, et al.
Published: (2009-01-01)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
by: Zhenzhen Yang, et al.
Published: (2019-08-01)

Correction: Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
by: Xing Guo, et al.
Published: (2024-01-01)

Clcf1/Crlf1a-mediated signaling is neuroprotective and required for Müller glia proliferation in the light-damaged zebrafish retina
by: Patrick Boyd, et al.
Published: (2023-02-01)

PB1784: CLADRIBINE SYNERGIZES THE EFFECT OF VENETOCLAX ON CELL PROLIFERATION ARREST AND APOPTOSIS BY TARGETING DNA-PKCS/C-MYC SIGNALING IN ACUTE MYELOID LEUKEMIA
by: Yue Hou, et al.
Published: (2023-08-01)